Literature DB >> 29995841

Pachychoroid disease.

Chui Ming Gemmy Cheung1,2,3, Won Ki Lee4, Hideki Koizumi5, Kunal Dansingani6, Timothy Y Y Lai7, K Bailey Freund8,9,10.   

Abstract

Pachychoroid is a relatively novel concept describing a phenotype characterized by attenuation of the choriocapillaris overlying dilated choroidal veins, and associated with progressive retinal pigment epithelium dysfunction and neovascularization. The emphasis in defining pachychoroid-related disorders has shifted away from simply an abnormally thick choroid (pachychoroid) toward a detailed morphological definition of a pathologic state (pachychoroid disease) with functional implications, which will be discussed in this review. Several clinical manifestations have been described to reside within the pachychoroid disease spectrum, including central serous chorioretinopathy, pachychoroid pigment epitheliopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization, focal choroidal excavation, peripapillary pachychoroid syndrome. These conditions all exhibit the characteristic choroidal alterations and are believed to represent different manifestations of a common pathogenic process. This review is based on both the current literature and the clinical experience of our individual authors, with an emphasis on the clinical and imaging features, management considerations, as well as current understanding of pathogenesis of these disorders within the context of the recent findings related to pachychoroid disease.

Entities:  

Mesh:

Year:  2018        PMID: 29995841      PMCID: PMC6328576          DOI: 10.1038/s41433-018-0158-4

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  106 in total

1.  Polypoidal Choroidal Vasculopathy: A Distinct Disease or Manifestation of Many?

Authors:  Chandrakumar Balaratnasingam; Won-Ki Lee; Hideki Koizumi; Kunal Dansingani; Maiko Inoue; K Bailey Freund
Journal:  Retina       Date:  2016-01       Impact factor: 4.256

Review 2.  Optical coherence tomography: imaging of the choroid and beyond.

Authors:  Sarah Mrejen; Richard F Spaide
Journal:  Surv Ophthalmol       Date:  2013-08-02       Impact factor: 6.048

3.  CHOROIDAL MORPHOLOGY IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY AND NORMAL OR SUBNORMAL SUBFOVEAL CHOROIDAL THICKNESS.

Authors:  Won Ki Lee; Jiwon Baek; Kunal K Dansingani; Jae Hyung Lee; K Bailey Freund
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

4.  The expanded spectrum of focal choroidal excavation.

Authors:  Ron Margolis; Sri Krishna Mukkamala; Lee M Jampol; Richard F Spaide; Michael D Ober; John A Sorenson; Ronald C Gentile; Joel A Miller; Jerome Sherman; K Bailey Freund
Journal:  Arch Ophthalmol       Date:  2011-06-13

5.  Pachychoroid pigment epitheliopathy may masquerade as acute retinal pigment epitheliitis.

Authors:  Claudine E Pang; K Bailey Freund
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-22       Impact factor: 4.799

6.  Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy.

Authors:  L A Yannuzzi; K B Freund; M Goldbaum; B Scassellati-Sforzolini; D R Guyer; R F Spaide; D Maberley; D W Wong; J S Slakter; J A Sorenson; Y L Fisher; D A Orlock
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

7.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

8.  EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY.

Authors:  Kunal K Dansingani; Chandrakumar Balaratnasingam; Jonathan Naysan; K Bailey Freund
Journal:  Retina       Date:  2016-03       Impact factor: 4.256

9.  Pachychoroid pigment epitheliopathy.

Authors:  David J Warrow; Quan V Hoang; K Bailey Freund
Journal:  Retina       Date:  2013-09       Impact factor: 4.256

10.  Digital indocyanine-green videoangiography of occult choroidal neovascularization.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; M Hope-Ross; D R Orlock
Journal:  Ophthalmology       Date:  1994-10       Impact factor: 12.079

View more
  113 in total

1.  Surgical outcomes of vitrectomy for breakthrough vitreous hemorrhage in eyes with exudative age-related macular degeneration.

Authors:  Takehito Iwase; Takayuki Baba; Yuya Saito; Tomohiro Nizawa; Hirotaka Yokouchi; Mariko Kubota-Taniai; Masayasu Kitahashi; Shuichi Yamamoto
Journal:  Int Ophthalmol       Date:  2021-02-21       Impact factor: 2.031

2.  Long-term follow-up of pachychoroid pigment epitheliopathy and lesion characteristics.

Authors:  Murat Karacorlu; M Giray Ersoz; Serra Arf; Mumin Hocaoglu; Isil Sayman Muslubas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-09-21       Impact factor: 3.117

3.  One-year results of intravitreal conbercept in treatment-naïve subjects with polypoidal choroidal vasculopathy.

Authors:  Lin-Hong Ye; Yi Cai; Xuan Shi; Ian Yat Hin Wong; Jin-Feng Qu; Ming-Wei Zhao; Xin Ying; Xiao-Xin Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-04       Impact factor: 3.117

4.  Utility of a public-available artificial intelligence in diagnosis of polypoidal choroidal vasculopathy.

Authors:  Jingyuan Yang; Chenxi Zhang; Erqian Wang; Youxin Chen; Weihong Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-04       Impact factor: 3.117

5.  Polypoidal choroidal vasculopathy in pachychoroid: combined treatment with photodynamic therapy and aflibercept.

Authors:  Maria Vadalà; Massimo Castellucci; Giulia Guarrasi; Giovanni Cillino; Vincenza Maria Elena Bonfiglio; Alessandra Casuccio; Salvatore Cillino
Journal:  Int Ophthalmol       Date:  2022-01-16       Impact factor: 2.031

6.  Comment on: Flat irregular pigment epithelium detachment in central serous chorioretinopathy: Correlation with choroidal neovascular membrane.

Authors:  Preetkanwar Singh Sodhi
Journal:  Indian J Ophthalmol       Date:  2020-04       Impact factor: 1.848

7.  Response of neovascular central serous chorioretinopathy to an extended upload of anti-VEGF agents.

Authors:  Benedikt Schworm; Nikolaus Luft; Leonie F Keidel; Felix Hagenau; Christoph Kern; Tina Herold; Karsten U Kortuem; Siegfried G Priglinger; Jakob Siedlecki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-02-28       Impact factor: 3.117

Review 8.  Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options.

Authors:  Francesco Sartini; Michele Figus; Marco Nardi; Giamberto Casini; Chiara Posarelli
Journal:  Eye (Lond)       Date:  2019-03-01       Impact factor: 3.775

9.  Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study.

Authors:  Claudio Iovino; Enrico Peiretti; Filippo Tatti; Giuseppe Querques; Enrico Borrelli; Riccardo Sacconi; Jay Chhablani; Hitesh Agrawal; Camiel J F Boon; Elon H C van Dijk; Gilda Cennamo; Marco Lupidi; Alessio Muzi; Valentina Di Iorio; Matias Iglicki; Lital Smadar; Anat Loewenstein; Dinah Zur
Journal:  Eye (Lond)       Date:  2021-04-06       Impact factor: 3.775

10.  Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy.

Authors:  Koji Tanaka; Ryusaburo Mori; Yu Wakatsuki; Hajime Onoe; Akiyuki Kawamura; Hiroyuki Nakashizuka
Journal:  J Clin Med       Date:  2021-05-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.